XETRA : 2M6.DE
-$0.6 (-0.81%)
XETRA
Geoffrey Straub Martha
Medical - Specialties
Healthcare
2M6.DE
95000
IE
EUR
0.57
2.13
1.62
0.17
0.76
$36.36B
3.01
2.21
20.14
4.23
$3.73
$4.8B
13.20%
16.87%
9.85%
5.16%
22.77
6.89
6.89
3/5
49 Analysts
%
2.80
8/9
$13.13B
$93.03B
$42.96B
$6.55B
No key metrics data available.
| Name | Title |
|---|---|
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer |
| Alex Gu | Senior VP & President of Greater China Region |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary |
| Brett A. Wall | Executive Officer |
| Thierry Pieton | Executive Vice President & Chief Financial Officer |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer |
| Ingrid Goldberg | Vice President & Head of Investor Relations |
No votes yet today — be the first to share your view!
About Medtronic Plc (XETRA:2M6.DE) Stock
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitorin ... g systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Frequently Asked Questions
What is the current Medtronic Plc (2M6.DE) stock price?
Medtronic Plc(XETRA:2M6.DE) stock price is $73.54 in the last trading session. During the trading session, 2M6.DE stock reached the peak price of $91.5 while $62.86 was the lowest point it dropped to. The percentage change in 2M6.DE stock occurred in the recent session was --0.81% while the dollar amount for the price change in 2M6.DE stock was -$0.6.
2M6.DE's industry and sector of operation?
The XETRA listed 2M6.DE is part of Medical - Specialties industry that operates in the broader Healthcare sector.
Who are the executives of 2M6.DE?
Geoffrey Straub Martha
| Chairman of the Board & Chief Executive Officer
Laura Mauri
| Senior Vice President and Chief Scientific & Medical Officer
Alex Gu
| Senior VP & President of Greater China Region
Michelle Quinn
| Executive Vice President, General Counsel & Secretary
Brett A. Wall
| Executive Officer
How many employees does 2M6.DE have?
Number of 2M6.DE employees currently stands at 95000. 2M6.DE operates from Building Two, Galway, GA 48619, IE.
Link for 2M6.DE official website?
Official Website of 2M6.DE is: https://www.medtronic.com
How do I contact 2M6.DE?
2M6.DE could be contacted at phone #353 1 438 1700 and can also be accessed through its website. 2M6.DE operates from Building Two, Galway, GA 48619, IE.
How many shares of 2M6.DE are traded daily?
The average number of 2M6.DE shares traded daily for last 3 months was 2.23K.
What is the market cap of 2M6.DE currently?
The market value of 2M6.DE currently stands at $94.13B with its latest stock price at $73.54